Your browser doesn't support javascript.
loading
Risk factors and outcomes of vocal cord paralysis after lung transplantation - a retrospective cohort study.
Seeliger, Benjamin; Drick, Nora; Avsar, Murat; Tudorache, Igor; Welte, Tobias; Gottlieb, Jens; Greer, Mark.
Afiliación
  • Seeliger B; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
  • Drick N; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
  • Avsar M; Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery, Hanover Medical School, Hanover, Germany.
  • Tudorache I; Department of Cardiac, Thoracic, Transplantation, and Vascular Surgery, Hanover Medical School, Hanover, Germany.
  • Welte T; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
  • Gottlieb J; Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), German Centre for Lung Research (DZL), Hannover, Germany.
  • Greer M; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Transpl Int ; 32(6): 626-634, 2019 Jun.
Article en En | MEDLINE | ID: mdl-30663812
ABSTRACT
Vocal cord paralysis (VCP) may complicate thoracic surgery and is associated with increased morbidity and mortality. Among lung transplant (LTx) recipients, chronic pulmonary aspiration can contribute to chronic allograft dysfunction (CLAD). We herein assessed the unknown incidence and clinical impact of VCP in a large LTx cohort. All first-time bilateral LTx recipients, transplanted between January 2010 and June 2015 were included in a single-centre retrospective analysis. Bronchoscopy reports were assessed for VCP. Patients exhibiting VCP were compared to propensity score-matched negative controls regarding CLAD onset and graft survival and secondary end-points, including inpatient duration and complications; lower respiratory tract infections (LRTI) within 24 months. In total, 583/713 (82%) patients were included in the analysis. A total of 52 (8.9%) exhibited VCP, which was transient in 34/52 patients (65%), recovering after median 6 months (IQR 2-12). Compared to 268 controls, 3-year graft survival and CLAD-free survival were non-inferior in VCP [HR 0.74 (95% CI 0.35-1.57), and HR 0.74 (95% CI 0.39-1.41)] respectively. Duration of hospitalization was similar and no differences in LRTI rates or airway complications were observed. Lower pre-Tx BMI increased risk for VCP [HR 0.88 (95% CI 0.79-0.99)]. Overall, VCP did not adversely affect graft and CLAD-free survival and secondary outcomes including LRTIs and hospitalizations.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Parálisis de los Pliegues Vocales / Trasplante de Pulmón / Enfermedades Pulmonares Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Int Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Parálisis de los Pliegues Vocales / Trasplante de Pulmón / Enfermedades Pulmonares Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Int Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Alemania